phenytoin has been researched along with Dizzyness in 12 studies
Excerpt | Relevance | Reference |
---|---|---|
" We compared length of hospital stay (and reported dizziness) in TBI patients receiving the commonest AEDs used in our TBI patients, Phenytoin (which may cause imbalance), and Levetiracetam (which does not affect balance)." | 3.96 | Impact of anti-epileptic drug choice on discharge in acute traumatic brain injury patients. ( Harris, L; Hateley, S; Seemungal, BM; Tsang, KT; Wilson, M, 2020) |
"Gabapentin is an anticonvulsant drug that has analgesic properties for acute postoperative pain." | 2.74 | The analgesic effect of gabapentin as a prophylactic anticonvulsant drug on postcraniotomy pain: a prospective randomized study. ( Aykac, B; Bingol, CA; Karlikaya, G; Sayin, M; Türe, H; Türe, U, 2009) |
" The pharmacokinetic assessment was repeated on day 18." | 2.69 | Lack of pharmacokinetic drug interactions between tiagabine and carbamazepine or phenytoin. ( Boellner, SW; Cao, GX; Cato, A; Guenther, HJ; Gustavson, LE; Qian, JX; Sommerville, KW, 1998) |
" Two analyses of adverse events are presented: tolerability and safety." | 2.69 | Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study. ( Bernstein, P; Faught, RE; Holmes, GL; Magnus-Miller, L; McLean, MJ; Morrell, MJ; Privitera, MD; Rose-Legatt, A; Willmore, LJ, 1999) |
"The gabapentin dosage was titrated to effective tolerated dose up to 2400 mg/day." | 2.69 | Gabapentin as adjunctive therapy for partial seizures. ( Bruni, J, 1999) |
"Perampanel (PER) is a new antiepileptic drug (AED) with a novel mechanism of action." | 1.51 | Clinical profiles associated with serum perampanel concentrations in children with refractory epilepsy. ( Ishikawa, N; Kobayashi, M; Kobayashi, Y; Tani, H; Tateishi, Y, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (25.00) | 18.7374 |
1990's | 4 (33.33) | 18.2507 |
2000's | 2 (16.67) | 29.6817 |
2010's | 2 (16.67) | 24.3611 |
2020's | 1 (8.33) | 2.80 |
Authors | Studies |
---|---|
Harris, L | 1 |
Hateley, S | 1 |
Tsang, KT | 1 |
Wilson, M | 1 |
Seemungal, BM | 1 |
Ishikawa, N | 1 |
Tateishi, Y | 1 |
Tani, H | 1 |
Kobayashi, Y | 1 |
Kobayashi, M | 1 |
Zappia, CP | 1 |
Piccirillo, B | 1 |
Türe, H | 1 |
Sayin, M | 1 |
Karlikaya, G | 1 |
Bingol, CA | 1 |
Aykac, B | 1 |
Türe, U | 1 |
Soslow, AR | 1 |
Fleishaker, JC | 1 |
Pearson, LK | 1 |
Peters, GR | 1 |
Gustavson, LE | 1 |
Cato, A | 1 |
Boellner, SW | 1 |
Cao, GX | 1 |
Qian, JX | 1 |
Guenther, HJ | 1 |
Sommerville, KW | 1 |
McLean, MJ | 1 |
Morrell, MJ | 1 |
Willmore, LJ | 1 |
Privitera, MD | 1 |
Faught, RE | 1 |
Holmes, GL | 1 |
Magnus-Miller, L | 1 |
Bernstein, P | 1 |
Rose-Legatt, A | 1 |
Bruni, J | 1 |
Pappas, DG | 1 |
Crawford, W | 1 |
Dorn, JM | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Gabapentin Regimens and Their Effects on Opioid Consumption[NCT03334903] | Phase 4 | 77 participants (Actual) | Interventional | 2018-05-15 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Surgical site pain. Scale 0-10, with 0 best and 10 worst (NCT03334903)
Timeframe: 2-3 months after surgery (at 2nd postoperative appointment)
Intervention | score on 10-point scale (Mean) |
---|---|
Standard of Care | 2.26 |
Postoperative Gabapentin Regimen | 2.46 |
Surgical site pain. Scale 0-10, with 0 best and 10 worst. (NCT03334903)
Timeframe: 2-3 months following surgery (measured at second postoperative appointment).
Intervention | score on a 10-point scale (Mean) |
---|---|
Standard of Care | 3.84 |
Postoperative Gabapentin Regimen | 3.54 |
Sleep quality. Scale 0-10 with 0 worst and 10 best. (NCT03334903)
Timeframe: 2-3 months following surgery (measured at second postoperative appointment).
Intervention | score on a 10-point scale (Mean) |
---|---|
Standard of Care | 5.73 |
Postoperative Gabapentin Regimen | 6.38 |
Nausea. Scale 0-10, with 0 best and 10 worst. (NCT03334903)
Timeframe: 2-3 months following surgery (measured at second postoperative appointment).
Intervention | score on a 10-point scale (Mean) |
---|---|
Standard of Care | 0.36 |
Postoperative Gabapentin Regimen | 0.17 |
Satisfaction. Scale 0-10 with 0 worst and 10 best. (NCT03334903)
Timeframe: 2-3 months following surgery (measured at second postoperative appointment).
Intervention | score on a 10-point scale (Mean) |
---|---|
Standard of Care | 7.83 |
Postoperative Gabapentin Regimen | 8.48 |
Number of days until patients are finished consuming opioid medications after discharge. (NCT03334903)
Timeframe: 2-3 months following surgery (measured at second postoperative appointment).
Intervention | days (Mean) |
---|---|
Standard of Care | 14.8 |
Postoperative Gabapentin Regimen | 18.7 |
Mean opioid consumption, measured in mg of morphine equivalents. (NCT03334903)
Timeframe: 2-3 months following surgery (total amount measured at second postoperative appointment; means assessed afterwards).
Intervention | morphine equivalents (Mean) |
---|---|
Standard of Care | 287.0 |
Postoperative Gabapentin Regimen | 281.1 |
5 trials available for phenytoin and Dizzyness
Article | Year |
---|---|
The analgesic effect of gabapentin as a prophylactic anticonvulsant drug on postcraniotomy pain: a prospective randomized study.
Topics: Administration, Oral; Adult; Amines; Analgesia, Patient-Controlled; Analgesics; Analgesics, Opioid; | 2009 |
Induction of tirilazad clearance by phenytoin.
Topics: Adult; Anticonvulsants; Antioxidants; Ataxia; Cross-Over Studies; Dizziness; Dose-Response Relations | 1998 |
Lack of pharmacokinetic drug interactions between tiagabine and carbamazepine or phenytoin.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Dizziness; Drug Interactions; Drug Monitoring; Dr | 1998 |
Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study.
Topics: Acetates; Adolescent; Adult; Ambulatory Care; Amines; Anticonvulsants; Asthenia; Carbamazepine; Cycl | 1999 |
Gabapentin as adjunctive therapy for partial seizures.
Topics: Acetates; Adult; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Dizziness; Dru | 1999 |
7 other studies available for phenytoin and Dizzyness
Article | Year |
---|---|
Impact of anti-epileptic drug choice on discharge in acute traumatic brain injury patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Brain Injuries, Traumatic; Dizziness; F | 2020 |
Clinical profiles associated with serum perampanel concentrations in children with refractory epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Dizziness; Drug Resistant Epile | 2019 |
Ataxia and dizziness in a patient on hemodialysis.
Topics: Anticonvulsants; Ataxia; Dizziness; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phenytoin; R | 2014 |
Psychomotor seizures.
Topics: Abdomen; Adult; Dizziness; Electroencephalography; Epilepsy, Temporal Lobe; Female; Humans; Pain; Ph | 1984 |
Index of suspicion.
Topics: Adolescent; Anticonvulsants; Ataxia; Cellulitis; Child; Child, Preschool; Creatinine; Diagnosis, Dif | 2002 |
Dizziness due to dysautonomia: response to specific therapy.
Topics: Autonomic Nervous System Diseases; Dizziness; Female; Humans; Middle Aged; Phenytoin | 1988 |
A case of phenytoin toxicity possibly precipitated by trazodone.
Topics: Adult; Dizziness; Drug Interactions; Humans; Male; Phenytoin; Schizophrenia, Paranoid; Seizures; Tra | 1986 |